Search Results

Cover Focus

Insights Into Fellowship and Beyond

Educators comment on the glaucoma training experience and transition to practice.

Ian Conner, MD, PhD; Reza Razeghinejad, MD; Erin Sieck, MD; Robert T. Chang, MD; Lucy Q. Shen, MD; Shivani Kamat, MD; Kelly W. Muir, MD, MHSc; and David A. Crandall, MD

Case Files

Unexpected Field Changes

Testing demonstrates improvement after surgery.

Devesh K. Varma, MD, FRCSC; Ronald L. Fellman, MD; Andrew Gross, MD; and Kelly W. Muir, MD, MHSc

Cover Focus

Educating the Next Generation of Surgeons

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Kelly W. Muir, MD, MHSc; and Rikki Enzor, MD, PhD

Case Files

Pigment Dispersion Glaucoma

The iridotomy dilemma.

Devesh K. Varma, MD, FRCSC; Shan C. Lin, MD; James Liu, MD; and Kelly W. Muir, MD, MHSc

Patients' Treatment Preferences

For most patients, starting an eye drop is the simplest first step.

Atalie C. Thompson, MD, MPH, and Kelly W. Muir, MD, MHS

Patients' Treatment Preferences

For most patients, starting an eye drop is the simplest first step.

Atalie C. Thompson, MD, MPH, and Kelly W. Muir, MD, MHS

Determining Factors in Intensifying Glaucoma Management

Take the whole patient into account.

Kelly W. Muir, MD, MHSc

Perspectives on Tertiary Care Glaucoma

Leveraging technology to strengthen collaborative care.

Kelly W. Muir, MD

Therapeutics Update

Are Your Patients Instilling Their Drops?

Glaucoma Today asked several members of the glaucoma community the following question: How do you know whether patients are using their topical glaucoma medications?

Henry D. Jempel, MD, MHS; Kelly W. Muir, MD; Gary D. Novack, PHD; and Alan L. Robin, MD